| J9271 | Injection, pembrolizumab, 1 mg | 12,000 | $40 | $516K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,570 | $40 | $59.7K |
| J0897 | Injection, denosumab, 1 mg | 2,640 | $20 | $50.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 420 | $100 | $42.4K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 480 | $80 | $37.9K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 1,390 | $20 | $32K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,420 | $20 | $31.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 300 | $70 | $20.6K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 60 | $120 | $7.1K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 140 | $50 | $7K |